Literature DB >> 23749587

An in vitro metabolic system of gut flora and the metabolism of ginsenoside Rg3 and cholic acid.

Chunyan Zhao1, Runbin Sun, Bei Cao, Shenghua Gu, Jieyu Zhao, Linsheng Liu, Xinwen Wang, Weibin Zha, Xiaoyi Yu, Wenjing Xiao, Yong Mao, Chun Ge, Jiaqi Ju, Lixiang Aa, Fei Fei, Yi Ding, Jiye Aa, Guangji Wang.   

Abstract

For orally administered drugs, the metabolism of a drug by the gut flora plays an important role in the bioavailability, activation and disposition of the drug in vivo. However, no in vitro system is currently available to evaluate the metabolism of a drug by the gut flora before the drug is absorbed into the body. This paper presents an in vitro metabolic system in an anaerobic environment that could be used to evaluate the metabolism of an endogenous compound, cholic acid, and a xenobiotic compound, ginsenoside Rg3. We showed that the proliferation of the anaerobic bacteria of the gut content of hamsters produced a similar composition of gut flora in a culture medium for yeast to that in vivo. Incubation of ginsenoside Rg3 and cholic acid in the anaerobic in vitro system efficiently produced the metabolites Rh2 and deoxycholic acid, respectively, similar to those seen in the gut content in vivo. In comparison with in vivo analysis, this anaerobic in vitro metabolic system is convenient, reproducible, economic and animal saving, and can easily be applied to assess the transformation and disposition of a drug before it enters into the circulatory system.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23749587     DOI: 10.1007/s13318-013-0143-z

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  21 in total

1.  Antitumor effects of ginsenoside Rg3 on human hepatocellular carcinoma cells.

Authors:  Chunle Zhang; Lingjun Liu; Yang Yu; Bin Chen; Chengwei Tang; Xiao Li
Journal:  Mol Med Rep       Date:  2012-02-23       Impact factor: 2.952

Review 2.  Cytochrome P450-mediated metabolism in the human gut wall.

Authors:  Kirstin Thelen; Jennifer B Dressman
Journal:  J Pharm Pharmacol       Date:  2009-05       Impact factor: 3.765

3.  Metabolism of kalopanaxsaponin B and H by human intestinal bacteria and antidiabetic activity of their metabolites.

Authors:  D H Kim; K W Yu; E A Bae; H J Park; J W Choi
Journal:  Biol Pharm Bull       Date:  1998-04       Impact factor: 2.233

4.  Metabolism of cholic acid in germfree animals after the establishment in the intestinal tract of deconjugating and 7 alpha-dehydroxylating bacteria.

Authors:  B E Gustafsson; T Midtvedt; A Norman
Journal:  Acta Pathol Microbiol Scand       Date:  1968

Review 5.  Techniques for microfloral and associated metabolic studies in relation to the absorption and enterohepatic circulation of drugs.

Authors:  H P Illing
Journal:  Xenobiotica       Date:  1981-12       Impact factor: 1.908

6.  Metagenomic analysis of the human distal gut microbiome.

Authors:  Steven R Gill; Mihai Pop; Robert T Deboy; Paul B Eckburg; Peter J Turnbaugh; Buck S Samuel; Jeffrey I Gordon; David A Relman; Claire M Fraser-Liggett; Karen E Nelson
Journal:  Science       Date:  2006-06-02       Impact factor: 47.728

7.  Metabolic analysis of rhubarb extract by rat intestinal bacteria using liquid chromatography-tandem mass spectrometry.

Authors:  Rui Song; Lei Xu; Fengguo Xu; Haijuan Dong; Yuan Tian; Zunjian Zhang
Journal:  Biomed Chromatogr       Date:  2011-03       Impact factor: 1.902

Review 8.  Role of intestinal flora in metabolism of agrochemicals conjugated with glutathione.

Authors:  J E Bakke; J A Gustafsson
Journal:  Xenobiotica       Date:  1986 Oct-Nov       Impact factor: 1.908

9.  Identification of rutin deglycosylated metabolites produced by human intestinal bacteria using UPLC-Q-TOF/MS.

Authors:  Jing Yang; Dawei Qian; Shu Jiang; Er-xin Shang; Jianming Guo; Jin-ao Duan
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2012-04-25       Impact factor: 3.205

10.  Comparative metagenomics revealed commonly enriched gene sets in human gut microbiomes.

Authors:  Ken Kurokawa; Takehiko Itoh; Tomomi Kuwahara; Kenshiro Oshima; Hidehiro Toh; Atsushi Toyoda; Hideto Takami; Hidetoshi Morita; Vineet K Sharma; Tulika P Srivastava; Todd D Taylor; Hideki Noguchi; Hiroshi Mori; Yoshitoshi Ogura; Dusko S Ehrlich; Kikuji Itoh; Toshihisa Takagi; Yoshiyuki Sakaki; Tetsuya Hayashi; Masahira Hattori
Journal:  DNA Res       Date:  2007-10-03       Impact factor: 4.458

View more
  4 in total

1.  In vitro assessment of the glucose-lowering effects of berberrubine-9-O-β-D-glucuronide, an active metabolite of berberrubine.

Authors:  Na Yang; Run-Bin Sun; Xing-Long Chen; Le Zhen; Chun Ge; Yu-Qing Zhao; Jun He; Jian-Liang Geng; Jia-Hua Guo; Xiao-Yi Yu; Fei Fei; Si-Qi Feng; Xuan-Xuan Zhu; Hong-Bo Wang; Feng-Hua Fu; Ji-Ye Aa; Guang-Ji Wang
Journal:  Acta Pharmacol Sin       Date:  2017-01-02       Impact factor: 6.150

2.  A metabolomic and pharmacokinetic study on the mechanism underlying the lipid-lowering effect of orally administered berberine.

Authors:  Shenghua Gu; Bei Cao; Runbin Sun; Yueqing Tang; Janice L Paletta; Xiaolei Wu; Xiao-Lei Wu; Linsheng Liu; Weibin Zha; Chunyan Zhao; Yan Li; Jason M Ridlon; Jason M Radlon; Phillip B Hylemon; Huiping Zhou; Jiye Aa; Guangji Wang
Journal:  Mol Biosyst       Date:  2014-11-20

3.  Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway.

Authors:  Runbin Sun; Na Yang; Bo Kong; Bei Cao; Dong Feng; Xiaoyi Yu; Chun Ge; Jingqiu Huang; Jianliang Shen; Pei Wang; Siqi Feng; Fei Fei; Jiahua Guo; Jun He; Nan Aa; Qiang Chen; Yang Pan; Justin D Schumacher; Chung S Yang; Grace L Guo; Jiye Aa; Guangji Wang
Journal:  Mol Pharmacol       Date:  2016-12-08       Impact factor: 4.436

4.  Gut microbiota promotes cholesterol gallstone formation by modulating bile acid composition and biliary cholesterol secretion.

Authors:  Hai Hu; Wentao Shao; Qian Liu; Ning Liu; Qihan Wang; Jin Xu; Xin Zhang; Zhenkun Weng; Qifan Lu; Long Jiao; Chaobo Chen; Haidong Sun; Zhaoyan Jiang; Xiaoping Zhang; Aihua Gu
Journal:  Nat Commun       Date:  2022-01-11       Impact factor: 14.919

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.